Add Your Idea

Reduce the Testing Requirements for new Drugs

Comment 5th July 2010

I think the testing requirements for new drugs and other medical treatments may have gone too far towards the "precautionary principal." Every tragic case of a new drug turning out to have dangerous side effects pushes us a bit further the same way, whereas countless cases of people dying, or having greately reduced quality of life for want of new treatments goes unremarked.

Getting a treatment to market is now so expensive that only a handful of companies can now afford to attempt it, creating a kind of complex monopoly. Treatements derived from proper, open, scientific research tend to be unpatentable, and consequently nobody will fund the necessary trials.

Why does this matter?

I think we desparately need to open up the development of drugs to new, smaller players. While the industry is completely dominated by a handful of multi-nationals they can cherry pick the most profitable targets. In particular there's more money in supportive treatment than in cures. More profit in the minor ailments of the developed world than in the killer diseases of the third world.

 


Highlighted posts


Add Your Idea

Comment on this idea

Good idea? Bad idea? Let us know your thoughts.


Back to top
Add Your Idea